 LOS ANGELES, June 30, 2021 GLOBE NEWSWIRE -- NASDAQ: ENOB Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Dr. Serhat Gumrukçu, co-founder and inventor of Enochian BioSciences and Director of Seraph Research Institute SRI, presented data demonstrating daily reduction of Hepatitis B Virus HBV until it could no longer be detected by the 8th day. No toxicities to the liver or other tissues were identified. The findings were presented during the prestigious International Liver Conference, and presentations can be found Link to presentations. 